Boston, MA, United States of America

Anna Gardberg

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Constellation Pharmaceuticals, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Gardberg. Retrieved from https://idiyas.com/inventor/anna-gardberg-r0yo2vqq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Anna Gardberg

Introduction

Anna Gardberg is an accomplished inventor based in Boston, MA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. Her work is characterized by a commitment to advancing healthcare through innovative solutions.

Latest Patents

Anna Gardberg holds one patent for her invention titled "Modulators of TREX1." This patent includes compounds of Formula (I) and pharmaceutically acceptable salts and compositions that are useful for treating a variety of conditions associated with TREX1. This innovation showcases her expertise in medicinal chemistry and her dedication to improving patient outcomes.

Career Highlights

Throughout her career, Anna has worked with Constellation Pharmaceuticals, Inc., where she has been instrumental in advancing research and development initiatives. Her role at the company has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical science.

Collaborations

Anna has collaborated with notable colleagues, including Victor S Gehling and Avinash Khanna. These partnerships have fostered a dynamic environment for innovation and have led to the successful development of new therapeutic approaches.

Conclusion

Anna Gardberg's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patent on TREX1 modulators highlights her commitment to addressing critical health challenges. Through her career and collaborations, she continues to pave the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…